Alpha Tau Medical Ltd. developed the Alpha DaRT therapy for solid tumors, leveraging technology from Tel Aviv University.

5 reports, 2 independent Updated Sep 2

Gone quiet

Reports: 5
Developments: 1
Repetition: 80%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Alpha Tau Medical Ltd. developed the Alpha DaRT therapy for solid tumors, leveraging technology from Tel Aviv University.

Who's involved

What this event is mainly about

Tel Aviv University

Keep exploring

Part of

Alpha Tau Medical Ltd. announced on September 2, 2025, that it has initiated a multi-center clinical trial in the United States. All 1 developments

The entities involved

Tel Aviv University
university in Tel Aviv, Israel
- Identifai Genetics, founded by Miller and Noam Shomron, is establishing a functional genomics research team at Tel Aviv University in Tel Aviv.Sat 00:49

Coverage

Newest first; wire copies grouped

Jun 28themarketsdaily.com
Aug 27GlobeNewswireAlpha Tau to Participate in Five September Investor Conferences JERUSALEM, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the develope

3 more outlets ran the same wire story